Insider Transactions in Q3 2022 at Evolent Health, Inc. (EVH)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 31
2022
|
Cheryl Scott Director |
SELL
Open market or private sale
|
Direct |
3,100
-5.72%
|
$111,600
$36.76 P/Share
|
|
Aug 24
2022
|
Frank J Williams Director |
SELL
Open market or private sale
|
Direct |
50,000
-6.23%
|
$1,850,000
$37.21 P/Share
|
|
Aug 24
2022
|
Frank J Williams Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+5.87%
|
$650,000
$13.95 P/Share
|
|
Aug 23
2022
|
Frank J Williams Director |
SELL
Open market or private sale
|
Direct |
150,000
-16.62%
|
$5,250,000
$35.75 P/Share
|
|
Aug 23
2022
|
Frank J Williams Director |
BUY
Exercise of conversion of derivative security
|
Direct |
150,000
+14.25%
|
$450,000
$3.84 P/Share
|
|
Aug 17
2022
|
John Paul Johnson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
18,434
-9.87%
|
$626,756
$34.11 P/Share
|
|
Aug 16
2022
|
Mary Bridget Duffy Director |
SELL
Open market or private sale
|
Direct |
7,500
-12.94%
|
$247,500
$33.13 P/Share
|
|
Aug 12
2022
|
Jonathan Weinberg General Counsel |
SELL
Open market or private sale
|
Direct |
14,335
-9.59%
|
$487,390
$34.96 P/Share
|
|
Aug 12
2022
|
Jonathan Weinberg General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
14,335
+8.75%
|
$143,350
$10.27 P/Share
|
|
Aug 01
2022
|
Aammaad Shams Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,247
+31.86%
|
-
|
|
Jul 01
2022
|
Steve Tutewohl Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,251
-2.08%
|
$69,781
$31.12 P/Share
|